These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11576528)

  • 1. Inhibition of lipoprotein-associated phospholipase A2 diminishes the death-inducing effects of oxidised LDL on human monocyte-macrophages.
    Carpenter KL; Dennis IF; Challis IR; Osborn DP; Macphee CH; Leake DS; Arends MJ; Mitchinson MJ
    FEBS Lett; 2001 Sep; 505(3):357-63. PubMed ID: 11576528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor.
    MacPhee CH; Moores KE; Boyd HF; Dhanak D; Ife RJ; Leach CA; Leake DS; Milliner KJ; Patterson RA; Suckling KE; Tew DG; Hickey DM
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):479-87. PubMed ID: 10024526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mildly oxidised LDL induces more macrophage death than moderately oxidised LDL: roles of peroxidation, lipoprotein-associated phospholipase A2 and PPARgamma.
    Carpenter KL; Challis IR; Arends MJ
    FEBS Lett; 2003 Oct; 553(1-2):145-50. PubMed ID: 14550563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions.
    Häkkinen T; Luoma JS; Hiltunen MO; Macphee CH; Milliner KJ; Patel L; Rice SQ; Tew DG; Karkola K; Ylä-Herttuala S
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2909-17. PubMed ID: 10591668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-associated phospholipase A2 decreases oxidized lipoprotein cellular association by human macrophages and hepatocytes.
    Yang M; Chu EM; Caslake MJ; Edelstein C; Scanu AM; Hill JS
    Biochim Biophys Acta; 2010 Feb; 1801(2):176-82. PubMed ID: 19895904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase.
    Dentan C; Tselepis AD; Chapman MJ; Ninio E
    Biochim Biophys Acta; 1996 Feb; 1299(3):353-7. PubMed ID: 8597590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein-associated phospholipase A2 as a target of therapy.
    Macphee CH; Nelson JJ; Zalewski A
    Curr Opin Lipidol; 2005 Aug; 16(4):442-6. PubMed ID: 15990594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A
    Otsuka F; Zhao X; Trout HH; Qiao Y; Wasserman BA; Nakano M; Macphee CH; Brandt M; Krug-Gourley S; Guo L; Ladich ER; Cheng Q; Davis HR; Finn AV; Virmani R; Kolodgie FD
    Atherosclerosis; 2017 Dec; 267():78-89. PubMed ID: 29101839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional impairment of two novel mutations detected in lipoprotein-associated phospholipase A2 (Lp-PLA2) deficiency patients.
    Ishihara M; Iwasaki T; Nagano M; Ishii J; Takano M; Kujiraoka T; Tsuji M; Hattori H; Emi M
    J Hum Genet; 2004; 49(6):302-307. PubMed ID: 15148590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme.
    Tselepis AD; Dentan C; Karabina SA; Chapman MJ; Ninio E
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1764-73. PubMed ID: 7583554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-associated PLA2 inhibition--a novel, non-lipid lowering strategy for atherosclerosis therapy.
    Leach CA; Hickey DM; Ife RJ; Macphee CH; Smith SA; Tew DG
    Farmaco; 2001; 56(1-2):45-50. PubMed ID: 11347966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lp-PLA2 silencing protects against ox-LDL-induced oxidative stress and cell apoptosis via Akt/mTOR signaling pathway in human THP1 macrophages.
    Zheng H; Cui D; Quan X; Yang W; Li Y; Zhang L; Liu E
    Biochem Biophys Res Commun; 2016 Sep; 477(4):1017-1023. PubMed ID: 27392709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated gene transfer of Lp-PLA2 reduces LDL degradation and foam cell formation in vitro.
    Turunen P; Jalkanen J; Heikura T; Puhakka H; Karppi J; Nyyssönen K; Ylä-Herttuala S
    J Lipid Res; 2004 Sep; 45(9):1633-9. PubMed ID: 15231855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins.
    Tew DG; Southan C; Rice SQ; Lawrence MP; Li H; Boyd HF; Moores K; Gloger IS; Macphee CH
    Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):591-9. PubMed ID: 8624782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein-associated phospholipase A2: a target directed at the atherosclerotic plaque.
    Suckling KE; Macphee CH
    Expert Opin Ther Targets; 2002 Jun; 6(3):309-14. PubMed ID: 12223071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OxLDL stimulates lipoprotein-associated phospholipase A2 expression in THP-1 monocytes via PI3K and p38 MAPK pathways.
    Wang WY; Li J; Yang D; Xu W; Zha RP; Wang YP
    Cardiovasc Res; 2010 Mar; 85(4):845-52. PubMed ID: 19910444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages.
    Sakai M; Miyazaki A; Hakamata H; Sato Y; Matsumura T; Kobori S; Shichiri M; Horiuchi S
    Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):600-5. PubMed ID: 8624783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, purification and characterization of a human serine-dependent phospholipase A2 with high specificity for oxidized phospholipids and platelet activating factor.
    Rice SQ; Southan C; Boyd HF; Terrett JA; MacPhee CH; Moores K; Gloger IS; Tew DG
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1309-15. PubMed ID: 9494101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
    Watson AD; Navab M; Hama SY; Sevanian A; Prescott SM; Stafforini DM; McIntyre TM; Du BN; Fogelman AM; Berliner JA
    J Clin Invest; 1995 Feb; 95(2):774-82. PubMed ID: 7860760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets inhibit the activity of platelet-activating factor acetylhydrolase in monocyte-derived macrophages.
    Pennewitz A; Finkelberg L; Krause S; Lösche W
    Thromb Res; 1997 Jun; 86(5):427-30. PubMed ID: 9211635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.